| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/24/2009 | US7495077 Homogeneous preparations of IL-28 and IL-29 |
| 02/24/2009 | US7494982 Modified oligonucleotides for telomerase inhibition |
| 02/24/2009 | US7494978 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/24/2009 | US7494977 Polypeptides homologous to VEGF and BMP1 |
| 02/24/2009 | US7494813 VAC-BAC shuttle vector system |
| 02/24/2009 | US7494812 Transforming lymphocytes with vector comprising gene sequences which code cytolethal distending toxin (cdt), leukotoxins and heat shock protein and generating regulatory cell which can be used to treat and/or prevent transplant rejection, autoimmune and inflammatory diseases; immunotherapy |
| 02/24/2009 | US7494810 Method for accessing microbial diversity |
| 02/24/2009 | US7494808 Methods and interferon deficient substrates for the propagation of viruses |
| 02/24/2009 | US7494807 Nutrient broth for propagation of hematopoietic stem cells |
| 02/24/2009 | US7494806 Genetic engineering; gene therapy; packaging cells; long terminal repeats; envelope genes/proteins |
| 02/24/2009 | US7494805 Expression cassette and vector for transient or stable expression of exogenous molecules |
| 02/24/2009 | US7494804 Polynucleotide encoding cytokine receptor zcytor17 multimer |
| 02/24/2009 | US7494801 Method of selecting Escherichia coli strain which highly expresses exogenous genes, Escherichia coli mutant strains selected by this method and process for producing enzymes and compounds using the same |
| 02/24/2009 | US7494800 Which transfer N-acetylgalactosamine to N-acetylglucosamine via beta 1-4 linkage; host cells |
| 02/24/2009 | US7494798 Polypeptides having cellulose 1,4-beta-cellobiosidase activity |
| 02/24/2009 | US7494797 Recombinant terminal deoxynucleotidyl transferase with improved functionality |
| 02/24/2009 | US7494796 Site directed mutagenesis; orthogonal tRNAs, orthogonal aminoacyl-tRNA synthetases; cells |
| 02/24/2009 | US7494793 21686, dehydrogenase |
| 02/24/2009 | US7494790 Preparing single stranded nucleotide sequences capable of forming stem-loop structures; for use as tools in gene expression analysis and amplification |
| 02/24/2009 | US7494788 Entropic bristle domain sequences and their use in recombinant protein production |
| 02/24/2009 | US7494786 Genetically engineered nuclear inclusion proteinase (NIa) comprising increased stability for obtaining large quantities of purified active proteins that form inclusion bodies in cells; modifying enzyme for premature polypeptides |
| 02/24/2009 | US7494785 Recombinant subunit vaccine |
| 02/24/2009 | US7494782 Assay for measuring factor viia-antithrombin complexes |
| 02/24/2009 | US7494777 Genomic sequence of the 5-lipoxygenase-activating protein (FLAP), polymorphic markers thereof and methods for detection of asthma |
| 02/24/2009 | US7494771 A rapid (10 to 15 minutes), simple, flexible and efficient method of nucleic acids extraction for nucleic acid testing assays |
| 02/24/2009 | US7494768 Mutational profiles in HIV-1 protease and reverse transcriptase correlated with phenotypic drug resistance |
| 02/24/2009 | US7494767 Assay for TSG101 as inhibitors of HIV production |
| 02/24/2009 | US7494666 Administering to a mammal a formualtion comprising cationic lipids/DNA complex, allowing the complex to associate with angiogenic endothelial cells of an angiogenic blood vessel for a time such that the complex enters the target cells |
| 02/24/2009 | US7494660 HCV NS3-NS4A protease resistance mutants |
| 02/24/2009 | US7494656 virus-like particle comprising at least one protein and mutein bound to influenza antigens or epitopes, used for inducing immune responsesv in particular antibody responses and for prevention or treatment of infections, allergies, cancer, drug addiction and poisoning |
| 02/24/2009 | US7494655 antigenic peptides, antibodies and carriers, diluents, excipients, adjuvants or auxiliary agents, use for inhibiting the formation of beta-amyloid; treatment of Alzheimer's disease or Down's syndrome |
| 02/24/2009 | US7494653 Inoculating a patient with an effective amount of PcrV antigen; monoclonal antibodies specific for the PcrV antigen |
| 02/24/2009 | US7494647 Chimeric immunoglobulin for prevention and treatment blood, tumor, cardiovascular and urogenital disorders |
| 02/24/2009 | US7494644 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair |
| 02/24/2009 | CA2415364C Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 02/24/2009 | CA2414978C Preparation of a recombinant protein in a prokaryotic host cell |
| 02/24/2009 | CA2396250C Mutant apre promoter |
| 02/24/2009 | CA2370372C Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
| 02/24/2009 | CA2360437C Method of acquiring immunological tolerance |
| 02/24/2009 | CA2322713C Process for the determination of ctp11 and for determining whether a tumor sample has metastatic potential |
| 02/24/2009 | CA2312943C Constitutive expression of non-infectious hiv-like particles |
| 02/24/2009 | CA2282746C Prediction of coronary artery disease |
| 02/24/2009 | CA2278892C A method for the production of dicarboxylic acids |
| 02/24/2009 | CA2272850C Genetic test for equine severe combined immunodeficiency disease |
| 02/24/2009 | CA2249061C Protein production process |
| 02/24/2009 | CA2245497C Peptide immunogens for vaccination against and treatment of allergy |
| 02/24/2009 | CA2214633C Antibody purification by low-ph hydrophobic interaction chromatography |
| 02/24/2009 | CA2194571C Novel amylolytic enzymes derived from the b. licheniformis .alpha.-amylase, having improved characteristics |
| 02/24/2009 | CA2179029C Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 02/24/2009 | CA2174556C Recombinant p53 adenovirus methods and compositions |
| 02/24/2009 | CA2150475C Phospholipase d gene originated from plant |
| 02/22/2009 | CA2639779A1 Algae essence nucleic acid fluid concentration preparation method |
| 02/19/2009 | WO2009023855A2 Tetrahydropyran nucleic acid analogs |
| 02/19/2009 | WO2009023755A1 Late blight resistance gene from wild potato |
| 02/19/2009 | WO2009023639A1 Modified peptides having toxin-enhancing effects |
| 02/19/2009 | WO2009023525A2 Methods of modulating mesenchymal stem cell differentiation |
| 02/19/2009 | WO2009023517A2 Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system |
| 02/19/2009 | WO2009023493A1 Methods and organisms for the growth-coupled production of 1,4-butanediol |
| 02/19/2009 | WO2009023416A2 Cosmetic methods and compositions for repairing human skin |
| 02/19/2009 | WO2009023360A2 Bacterial packaging strains useful for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof |
| 02/19/2009 | WO2009023347A2 Metal resistant plants, and methods of manufacture thereof |
| 02/19/2009 | WO2009023308A2 Genetically modified babesia parasites expressing protective tick antigens and uses thereof |
| 02/19/2009 | WO2009023270A2 Compositions and methods for modifying properties of biologically active polypeptides |
| 02/19/2009 | WO2009023265A1 Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof |
| 02/19/2009 | WO2009023184A2 Universal fibronectin type iii binding-domain libraries |
| 02/19/2009 | WO2009023043A1 Immunoglobulins directed to bacterial viral and endogenous polypeptides |
| 02/19/2009 | WO2009022939A1 Method for identifying the genotype and subtype of hepatitis c virus on a biological microchip |
| 02/19/2009 | WO2009022845A2 Promoter for the high level expression in plant-tissue culture and vector using the same |
| 02/19/2009 | WO2009022797A1 Mutant of propionyl-coa transferase from clostridium propionicum and preparing method for pla or pla copolymer using the same |
| 02/19/2009 | WO2009022683A1 Method of detecting target substance |
| 02/19/2009 | WO2009022682A1 Method of detecting target substance |
| 02/19/2009 | WO2009022656A1 Recombinant mammalian cells, method of producing recombinant mammalian cells and method of producing target protein |
| 02/19/2009 | WO2009022558A1 Microorganism detection method and microorganism detection kit |
| 02/19/2009 | WO2009022512A1 Method for obtaining information on formation of double-stranded nucleic acid |
| 02/19/2009 | WO2009022399A1 Novel microorganism having gastric juice promoting action and composition secreted by the same |
| 02/19/2009 | WO2009022216A2 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 02/19/2009 | WO2009022215A1 Combination motif immune stimulatory oligonucleotides with improved activity |
| 02/19/2009 | WO2009022183A1 Production of plants with decreased nitrite content |
| 02/19/2009 | WO2009022162A1 Bacillus with inactivated or downregulated htra and/or htrb |
| 02/19/2009 | WO2009022119A1 Murine endometriosis modelled by k-ras activation of menstruating endometrium |
| 02/19/2009 | WO2009021971A2 Novel targets and compounds for therapeutic intervention of hiv infection |
| 02/19/2009 | WO2009021875A1 Genes encoding the biosynthetic pathway for etnangien production |
| 02/19/2009 | WO2009021853A1 Eukaryotic promoters for gene expression |
| 02/19/2009 | WO2009021548A1 Expression of full length igg and secretion into the culture medium of prokaryotic cells |
| 02/19/2009 | WO2009021545A1 Promotor sequence and gene construct for increasing crop yield in tomato |
| 02/19/2009 | WO2009021468A1 Cell-penetrating peptides and use thereof bonded to biomolecules having therapeutic action |
| 02/19/2009 | WO2009021448A1 A plant height regulatory gene and uses thereof |
| 02/19/2009 | WO2009021338A1 Alternative splicing gene variants in cancer detection |
| 02/19/2009 | WO2009021325A1 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 02/19/2009 | WO2009021295A2 Inhibition of alpha synuclein toxicity |
| 02/19/2009 | WO2009021291A1 Mycobacterium vaccine formulation |
| 02/19/2009 | WO2009021288A1 Improved gene silencing methods |
| 02/19/2009 | WO2009021285A1 Barley with low levels of hordein |
| 02/19/2009 | WO2009021276A1 Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof |
| 02/19/2009 | WO2009006297A3 Methods for altering the genome of a monocot plant cell |
| 02/19/2009 | WO2009002832A3 Inhibitors of ncca-atp channels for therapy |
| 02/19/2009 | WO2009002198A3 Expression cassette, t-dna molecule, plant expression vector, transgenic plant cell as well as their use in the manufacturing of a vaccine |
| 02/19/2009 | WO2008156500A3 Methods of inducing or increasing the expression of proteoglycans such as aggrecan in cells |
| 02/19/2009 | WO2008152252A3 Rumc peptides with antimicrobial activity |
| 02/19/2009 | WO2008151200A3 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets |